Microbot Medical Inc.

MBOT Healthcare Medical Devices

Revenue
+1,047.6%
EPS
+20.0%
Free cash flow
−98.7%

Quarter to June 2026, against a year earlier

1.10 0.03 +2.80%
Market cap
$71.9M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
−19.40
Beneish M
n/a
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

(31.87%) (32.42%) (27.58%) (32.91%)
ROA
(30.06%) (30.01%) (26.09%) (30.68%)
ROIC
0.00% 0.00% (506.63%) (850.51%)
Return on Tangible Assets
(16.77%) (17.18%) (19.38%) (23.82%)
Average Days of Receivables
— — 198.47 155.51
Free Cash Flow per Share
(0.23) (0.29) (0.23) (0.27)
Free Cash Flow
(11.02) (13.11) (15.38) (17.93)
Other line items

Show all line items

Columns are period end dates